PharmacistColumn

Making #Pharmacy #Media Simple and Easy Since 2013. Join us on FACEBOOK at

[PharmacistColumn @RxColumn]

Lilly investigating allegations of $4.9M in Chinese bribes - FiercePharma: http://t.co/oH7jbQpCOo

[PharmacistColumn @RxColumn]

Risk specialists arrested in China http://t.co/IEtODyNCv2 via @PharmaTimes

[PharmacistColumn @RxColumn]

#Whistleblower: #Lilly spent $4.9M bribing Chinese docs to prescribe diabetes meds - FiercePharma: http://t.co/MeBeUdTvWS

[PharmacistColumn @RxColumn]

Short Sun Pharma, advises Manoj Murlidharan - CNBC-TV18 http://t.co/cl0I9aVgWj via @moneycontrolcom

[PharmacistColumn @RxColumn]

The Dry Pipeline For Psychiatric Drugs Doesn't Rest On Pharma's Shoulders http://t.co/ZZkduCmMV5 via @forbes

[PharmacistColumn @RxColumn]

EMA and US FDA release first conclusions of parallel assessment of quality-by-design applications http://t.co/ypnuXkFjmM

[PharmacistColumn @RxColumn]

Pharmacy Professor Working to Prevent Cancer Drug Shortages | UConn Today: http://t.co/x3h4g2gyhX via @UConn

[Honest Apothecary (AKA Jason) @jasonpoquette]

Pharmacy Ownership: 5 Challenges for the New Store Owner http://t.co/VvmuEN9qk3

[Stanford Medicine X @StanfordMedX]

[Clinicians] need to ask,"What do you think, what are we missing here? ... Medicine should be a team sport." @rzeiger http://t.co/yhq0qxDWzH

[PharmacistColumn @RxColumn]

Obamacare Will Be Price Competitive To What's On The Market, Insurers Say http://t.co/oOh6Qu7hvx via @forbes

[PharmacistColumn @RxColumn]

#Breakthrough status for #Novartis muscle wasting drug http://t.co/revmrAT7WD via @PharmaTimes

[PharmacistColumn @RxColumn]

Nuvo Sues Mallinckrodt Over Pennsaid Studies | Pharmalive http://t.co/plnJITC0AB

[PharmacistColumn @RxColumn]

NHS health MOTs under fire again http://t.co/aLO5OaS3yO via @PharmaTimes

[PharmacistColumn @RxColumn]

Exalenz BreathID Platform technology's liver application wins US patent http://t.co/4mCE2e89uy

[PharmacistColumn @RxColumn]

Article > Merck needs to cut costs, says analyst http://t.co/9vmJMRZUdp via @PharmaTimes

[PharmacistColumn @RxColumn]

Alexion pulls Soliris vials on particle-contamination worries - FiercePharma: http://t.co/eOmcmNjGlW

[PharmacistColumn @RxColumn]

First pre-clinical gene therapy study to reverse Rett symptoms http://t.co/31K9rXGLHB

[PharmacistColumn @RxColumn]

Alnylam obtains additional orphan drug designation for ALN-AT3 from FDA http://t.co/ZdRf5kPVGZ

[PharmacistColumn @RxColumn]

GW Pharma submits IND application with US FDA for Sativex phase III clinical trial http://t.co/CMc9STDYSt

[PharmacistColumn @RxColumn]

Novartis' Bexsero #vaccine receives Australian approval for #MenB disease http://t.co/fKQ06xYdWO